Treatment of STAT3-deficient hyper-immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation

Affiliations

• ¹ National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
• ² Department of Allergy and Immunology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
• ³ Department of Medicine, George Washington University, Washington, DC.
• ⁴ Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.
• ⁵ Department of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.
• ⁶ AllerVie Health, Allergy Asthma Immunology Center, Huntsville, AL.
• ⁷ Midwest Immunology, Plymouth, MN.
• ⁸ Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.
• ⁹ Division of Clinical Immunology and Allergy, Department of Pediatrics, Children's Hospital of Los Angeles, Keck School of Medicine of U.S.C, Los Angeles, CA.
• ¹⁰ National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD. Electronic address: freemaal@mail.nih.gov.